Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
schizophrenia
Pharma
Teva's innovative drugs helped carry strong Q1
Teva topped Wall Street estimates in 2026’s first quarter, buoyed by the impressive performance of branded drugs like Austedo, Uzedy and Ajovy.
Fraiser Kansteiner
Apr 29, 2026 2:27pm
Teva launches new online schizophrenia community project
Apr 15, 2026 9:45am
FDA signs off on Vanda's Bysanti for schizophrenia and bipolar I
Feb 23, 2026 11:35am
BMS' Cobenfy TV ad is latest target of FDA untitled letter spree
Dec 19, 2025 10:44am
BMS cooks up schizophrenia stigma-busting push with Gail Simmons
Oct 13, 2025 11:29am
BMS will charge same price in UK as its does in US for Cobenfy
Sep 22, 2025 12:05pm